BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2300478, PBX1, Metabolism of xenobiotics, Influenza, Stem cell, Alcohol, Tamoxifen)
Bookmark Forward

QuickView for TAC1 (gene)


Body Atlas

Most Correlated Tissues

  1. Caudate
  2. Putamen
  3. Accumbens
  4. Dorsal root ganglia
  5. Caudate nucleus
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Toxoplasmosis
  2. Huntington's disease
  3. Cytomegalovirus infection
  4. Infection due to Acinetobacter
  5. Disorder of basal ganglia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. di-Calciphor
  2. Fibroblast Growth Factor 8
  3. PDGFD protein, human
  4. Pituitary Adenylate Cyclase-Activating Polypeptide
  5. Fatty Acid Synthesis Inhibitors
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR31
  2. SMN2
  3. PDK1
  4. FSHR
  5. WT1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Rapid elucidation of agonist-driven regulation of the neurokinin 1 receptor using a GPCR phosphoryla…
  2. Substance P, a Neuropeptide, Promotes Wound Healing via Neurokinin-1 Receptor.
  3. PON1 has palmitoyl-protein thioesterase (PPT) activity, and can affect the presence of SR-B1 on the …
  4. Stimulation of the calcium-sensing receptor induces relaxations through CGRP and NK1 receptor-mediat…
  5. Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. EsophaCap for the Detection of Early Esophageal Carcinoma
  2. Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN)
  3. Improving Immunosuppressive Therapy in Heart Transplantation
  4. Precision Medicine for Sng/Pain Control
  5. Diagnostic Potential of Hypermethylated DNA in Colorectal Cancer
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.